Skip to main content
. 2017 Nov 18;6(11):e007564. doi: 10.1161/JAHA.117.007564

Table 2.

Study Baseline and Change From Study Baseline to Last In‐Study Measurement of BP, ECG LVH, QRS Duration, and Heart Rate in Relation to the Presence or Absence of ECG LVH by Both CP and SL at Baseline

Variables CP−/SL− (n=2023) CP+/SL− (n=5220) CP−/SL+ (n=990) CP+/SL+ (n=960) P Value
Baseline measurements
Systolic BP, mm Hg 172±14 174±14 176±14 176±143 <0.001
Diastolic BP, mm Hg 98±8 98±9 97±9 98±9 <0.001
CP, mm·ms 2065±393 3212±897 1715±518 3454±1239 <0.001
SL, mm 26.4±7.3 25.7±6.8 44.9±5.9 45.3±6.4 <0.001
QRS duration, ms 92.8±11.5 105.7±19.5 96.6±9.4 103.8±18.5 <0.001
Heart rate, beats per min 74.1±11.2 74.2±11.1 72.2±10.7 73.0±11.3 <0.001
Change from baseline to last measurement
Systolic BP, mm Hg −27.7±18.6 −29.4±19.4 −30.8±20.2 −31.3±21.4 <0.001
Diastolic BP, mm Hg −16.8±10.1 −17.2±10.2 −16.8±10.6 −17.8±11.0 <0.001
CP, mm·ms 13±659 −270±852 −13±790 −428±1140 <0.001
SL, mm −2.5±6.0 −2.8±6.5 −7.6±8.4 −8.6±9.1 <0.001
QRS duration, ms 2.7±11.5 1.5±12.3 1.4±13.1 1.4±13.2 <0.001
Heart rate, beats per min −4.8±12.7 −5.3±13.0 −5.1±12.6 −4.2±12.7 0.091

BP indicates blood pressure; CP, Cornell product; LVH, left ventricular hypertrophy; SL, Sokolow‐Lyon voltage.